Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents

Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents

Background: In more than 90% of chronic viral hepatitis C (HCV) patients treated with direct-acting antiviral agents (DAAs), a sustained viral response (SVR) was observed. Unfortunately, there are subgroups of subjects who display enduring liver fibrosis and are at high risk of developing hepatocell...

Full description

Bibliographic Details
Main Authors: Valentina Cossiga, Evelina La Civita, Dario Bruzzese, Maria Guarino, Andrea Fiorentino, Rosanna Sorrentino, Giuseppina Pontillo, Luca Vallefuoco, Stefano Brusa, Emma Montella, Daniela Terracciano, Filomena Morisco, Giuseppe Portella
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
ELF index
HCV
liver fibrosis
transient elastography (FibroScan)
direct-acting agents
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.891398/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.891398/full

Similar Items